RxDoctor Payments Data

Stanley Harvey

Internal Medicine · Stuart, FLNPI 1720027345

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.1% of the total across 74 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $948 and has fallen 99.2% since, to $8 in 2021.

$1,179in general payments, 2019–2025

Across 74 payments — averaging $15.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi-aventis U.S. LLC$196
  • Lilly USA, LLC$196
  • AstraZeneca$172
  • Johnson & Johnson$84
  • Novo Nordisk$78
  • Kowa Pharmaceuticals America, Inc.$65
  • plus $388 from 13 others

What the payments were for

  • Consulting fees$81%
  • Food & beverage$1,15898%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,179 in reported general payments places this provider in the 70th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida →

Other internal medicine in Stuart

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →